NYSE · traded in Congress
National Health Investors, NHI
$71.24 -0.34 (-0.47%) Nov 6, 2026
Market value$3.5B
P/E ratio-
Analyst target$80.00
52-week range-
Avg volume297,333
Dividend yield-
Chart
Earnings
National Health Investors reports Monday, November 9, after the close.
Analyst ratings
- 6 buy
- 3 hold
- 0 sell
Low target$65.00
Average target$78.56
High target$90.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $45M | - | $56M | 124.3% | |
| $37M | - | $40M | 108.2% | |
| $31M | - | $38M | 124.2% | |
| $21M | - | $33M | 155.2% |
New SEC filings
- 8-K 8-K filed Nov 9, 2026
- 8-K 8-K filed Nov 9, 2026
- 8-K 8-K filed Nov 9, 2026
- 10-Q 10-Q filed Nov 9, 2026
All NHI filings on SEC EDGAR ›
Congress trades in NHI
Members of Congress disclosed 1 transaction in NHI in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 07/10/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 9/4/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
